Categories AlphaGraphs, Earnings, LATEST, Other Industries

Earnings: JetBlue (JBLU) Q3 loss narrows on strong revenue growth; beats view

JetBlue Airways Corp. (NASDAQ: JBLU) reported a sharp increase in third-quarter revenues, reflecting the resumption of flight operations even as the market-reopening gathers momentum. As a result, net loss narrowed and beat the estimates.

JetBlue Q3 2021 earnings infographic

The company reported a net loss of $0.12 per share for the September quarter, on an adjusted basis, which is narrower than the loss analysts had forecast. On an unadjusted basis, it was a net profit of $130 million or $0.40 per share, compared to a loss of $393 million or $1.44 per share in the third quarter of 2020.

Third-quarter 2021 revenues increased multifold year-over-year to $1.97 billion and topped expectations.

“We believe that demand is once again poised to re-accelerate into the peak holiday periods and beyond as people continue to adjust to a new normal. We are marching towards a full recovery and a return to sustained profitability, with margin as our north star,” said Robin Hayes, JetBlue’s chief executive officer.


Read management/analysts’ comments on JetBlue’s Q3 results


Shares of JetBlue made modest gains in pre-market trading on Tuesday following the earnings announcement, after closing the previous session higher. In the past six months, the stock lost about 28%.

Prior Performance

  • JetBlue reports Q3 2020 earnings results

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top